Market revenue in 2023 | USD 155.4 million |
Market revenue in 2030 | USD 270.6 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Ctc detection & enrichment methods |
Fastest growing segment | CTC Analysis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 64.86% in 2023. Horizon Databook has segmented the Middle East & Africa circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.
Considerable increase in the prevalence of chronic and infectious diseases in the African region due to low living standards, unhealthy diet, and industrial & agricultural pollution, has led to an increase in the need for cheaper generic treatment. Moreover, the ongoing development of healthcare infrastructure is providing ample opportunities to support market growth.
The pricing policies in Saudi Arabia and regulatory framework reforms may further contribute to market growth by creating growth opportunities for local players. A greater proportion of people in African countries belong to the low-income group. Hence, the rise in demand for affordable substitutes coupled with availability of generic products is anticipated to drive the market.
In addition, government initiatives to increase the adoption of generic drugs for reducing healthcare costs are expected to drive growth of the branded generics market in the MEA.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa circulating tumor cells market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account